Class III · Low risk
Ceftriaxone for Injection USP
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Is Ceftriaxone recalled?
Yes — there is an active recall. 3 ongoing FDA recalls mention Ceftriaxone (38 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Ceftriaxone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Ceftriaxone recalls on record
none so far in 2026; 38 on record, newest first
Class III · Low risk
Ceftriaxone for Injection USP
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Class III · Low risk
Ceftriaxone for Injection USP
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.
Class II · Moderate risk
Ceftriaxone 2g/NS 100 mL Minibag Plus
Lack of Assurance of Sterility
Class II · Moderate risk
CEFTRIAXONE in NS
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II · Moderate risk
Ceftriaxone Sodium
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
CEFTRIAXONE SODIUM 2000mg / NS 50mL
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
CefTRIAXone Sodium
Lack of Assurance of Sterility: Sterility of product is not assured.
Class II · Moderate risk
Ceftriaxone various strengths in normal saline
Lack of sterility assurance.
Class II · Moderate risk
Ceftriaxone 1 gm/50 mL D5W
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Class II · Moderate risk
Ceftriaxone 2 gm/100 mL D5W
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Class II · Moderate risk
Ceftriaxone 2 gm/100 mL 0.9%NS
Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.
Class I · High risk
Ceftriaxone for Injection and Dextrose Injection
Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.